Vaxxinity Common Stock

The latest common stock for VAXX is $280K as of December 2023. That compares with $280K in the prior-year period — up 0.0% year over year. Investors often review this figure alongside Vaxxinity's historical trend and sector peers before judging valuation or financial health.

Over the past year, VAXX's common stock moved from $280K to $280K — essentially flat versus a year earlier. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Vaxxinity's operating scale or balance-sheet position.

A common stock figure of $280K for VAXX is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting VAXX's common stock ($280K), review year-over-year change from $280K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.